Open AccessThe Ex Vivo human placental transfer of the anti‐HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavir
Author(s) -
Roger E. Bawdon
Publication year - 1998
Publication title -
infectious diseases in obstetrics and gynecology
Language(s) - English
Resource type - Journals
eISSN - 1098-0997
pISSN - 1064-7449
DOI - 10.1002/(sici)1098-0997(1998)6:6<244::aid-idog4>3.3.co;2-2
Subject(s) - amprenavir , ritonavir , abacavir , ex vivo , trough concentration , pharmacology , chemistry , pharmacokinetics , in vivo , nucleoside , protease inhibitor (pharmacology) , reverse transcriptase inhibitor , protease , virology , biochemistry , medicine , biology , viral load , enzyme , hiv 1 protease , virus , reverse transcriptase , in vitro , antiretroviral therapy , rna , microbiology and biotechnology , gene